Qingdao Baheal Medical, Inc. (301015.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 21Aug 26Aug 31Sep 3Sep 8Sep 11Sep 16Sep 21

Key dataSep 21, 2026

OpenCNY 25.59

From 52W high−20.67%

Volume13.10M

Market capCNY 13.07B

P/E (TTM)27.5x

P/S (TTM)1.8x

Div yield2.23%

Key dataSep 21, 2026

Open

CNY 25.59

From 52W high

−20.67%

Volume

13.10M

Market cap

CNY 13.07B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

17.2x

P/E (TTM)

27.5x

RSI (14)

57.7

MomentumView details →

1D Return

−3.83%

YTD Return

+8.26%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

27.5x

EV/EBITDA

17.2x

EV/Sales

1.9x

P/S (TTM)

1.8x

P/B (TTM)

6.0x

ProfitabilityView details →

Gross Margin

38.36%

Net Margin

6.89%

EBITDA Margin

11.19%

ROE (TTM)

19.84%

ROA (TTM)

5.99%

Asset Turnover

0.89x

GrowthView details →

Revenue YoY

−7.89%

EPS YoY

−12.50%

FCF YoY

−40.72%

Revenue CAGR 3Y

−0.01%

EPS CAGR 3Y

−2.13%

EBITDA YoY

—

MomentumView details →

1D Return

−3.83%

YTD Return

+8.26%

1Y Return

−12.38%

RSI (14)

57.7

vs 50D SMA

+6.31%

vs 200D SMA

+9.86%

Capital & dividendView details →

Debt/Equity

1.14x

Current Ratio

1.43x

Quick Ratio

1.18x

Div Yield

2.23%

Div Rate

CNY 0.57

Div Growth 1Y

−25.07%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

CNY 0.00

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

7.45B

Net Income (TTM)

513.61M

Op. CF (TTM)

657.38M

Latest newsMore news →

Baheal Pharmaceutical plans to invest 40 million yuan in Tianjin Jikun Pharmaceutical Technology Co., Ltd., increasing its stake to 25.44%.24d ago

Baiyang Pharmaceutical announced its 2026 first-half results: revenue of 3.56 billion yuan, down 5.11% year-on-year; net profit attributable to shareholders of 225 million yuan, up 37.72% year-on-year.24d ago

Similar companies

厦门港务000905.SZ 周大生002867.SZ 力源信息300184.SZ 江苏国泰002091.SZ 国药一致000028.SZ 北方国际000065.SZ Find similar companies →

Latest newsMore news →

Baheal Pharmaceutical plans to invest 40 million yuan in Tianjin Jikun Pharmaceutical Technology Co., Ltd., increasing its stake to 25.44%.24d ago Baiyang Pharmaceutical announced its 2026 first-half results: revenue of 3.56 billion yuan, down 5.11% year-on-year; net profit attributable to shareholders of 225 million yuan, up 37.72% year-on-year.24d ago